Manager, Translational Science & Biomarker Method Development
Sumit Kar, PhD is the Manager of Translational Science & Biomarker Method Development at Celerion leading biomarker development for clinical trials. Sumit earned his PhD from the University of Nebraska Medical Center and has over 14 years of research experience in cardio-metabolic diseases. He has authored over 20 publications in the areas of bioanalysis, biomarkers, diabetes, and heart failure. Sumit also participates in working groups for the Global CRO Council (GCC) authoring White Papers promoting best practices for biomarker method development and validation and to educate the field on new technologies and assay design approaches. Sumit was recently chosen as a finalist for the Bioanalysis Rising Star Award.